Mrs. Shari A Taylor, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Opportunity Dr, Sheridan, AR 72150 Phone: 870-942-8335 Fax: 870-942-2234 |
Mrs. Lela Christine Mcanally, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Opportunity Drive, Sheridan, AR 72150 Phone: 870-942-8335 Fax: 870-942-2234 |
Sarah Drumm Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 S Rose St, Sheridan, AR 72150 Phone: 870-917-9292 |
Kathleen Lenahan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2163 Grant 74, Sheridan, AR 72150 Phone: 501-917-9835 |
Keystone Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3000 Grant 52, Sheridan, AR 72150 Phone: 870-941-3644 |
News Archive
A judge approved a $712 million health settlement for thousands of emergency workers who responded after the Sept. 11 attack, in spite of objections from some who complained that the deal was unfair. Some workers who say they got sick working at the Ground Zero site argued Wednesday that the settlement shortchanged those suffering from certain types of diseases. One of the key factors in how much workers get paid under the settlement, approved by U.S. District Judge Alvin Hellerstein, depends on the type of disease the person contracted.
Medco Health Solutions, Inc. (NYSE: MHS) is helping seniors in this tough economy find smart solutions for getting the most value out of their Medicare prescription drug plan.
Hubrecht Organoid Technology (HUB), and the health insurance companies CZ, Zilveren Kruis, and Menzis announced today that they will start a €3 million validation trial for use of HUB Organoid Technology to test if it can be used to determine the response of Cystic Fibrosis (CF) patients to new drug therapies.
Despite the fact that previous research shows the Appalachian region of the United States as limited in access to health care services, researchers at Nationwide Children's Hospital have found that children with special health care needs in Appalachian areas face similar levels of health status as their metropolitan counterparts.
Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.
› Verified 9 days ago